Trump diagnosed with common vein condition after ankle swelling raises concerns

Trump diagnosed with common vein condition after ankle swelling raises concerns


First Lady Melania Trump, President Donald Trump, FIFA President Gianni Infantino and his wife, Leena Al Ashqar, attend the FIFA Club World Cup 2025 final football match between England’s Chelsea and France’s Paris Saint-Germain at MetLife Stadium in East Rutherford, New Jersey, July 13, 2025.

Charly Triballeau | AFP | Getty Images

President Donald Trump underwent a comprehensive medical exam that revealed he has a common vein disorder but cleared him of more serious illnesses, the White House said Thursday.

The White House disclosed the 79-year-old president’s medical information in response to speculation after photos showed Trump with swollen ankles.

Press secretary Karoline Leavitt said Trump noticed the swelling in recent weeks and received a thorough evaluation by the White House medical unit.

He was diagnosed with chronic venous insufficiency, which Leavitt described as a “benign and common condition, particularly in individuals over the age of 70.”

Chronic venous insufficiency occurs when a person’s leg veins are damaged, restricting circulation and causing blood to pool in the legs, according to the Cleveland Clinic.

Chronic venous insufficiency affects about 1 in 20 adults, and the risk increases with age, according to the clinic.

Leavitt said Trump was not in any pain from the condition.

A bruise is visible on President Donald Trump’s right hand that appeared to be covered with makeup, as Trump waited to greet Crown Prince Salman bin Hamad Al Khalifa of Bahrain as he arrived outside the West Wing of the White House, July 16, 2025.

Mehmet Eser | AFP | Getty Images

Leavitt also addressed bruises periodically visible on the back of Trump’s hand. She said they were caused by irritation from “frequent handshaking,” coupled with his aspirin regimen.

The medical exam found no evidence of deep vein thrombosis or arterial disease, Leavitt said.

Trump’s blood test results were all within “normal limits,” and an echocardiogram confirmed “normal cardiac structure and function” with “no signs of heart failure, renal impairment or systemic illness,” she added.

Leavitt said in Thursday’s briefing that bruising like that seen on Trump’s hands is a common side effect of regularly using aspirin, which Trump takes as part of a “standard cardiovascular prevention regimen.”

“The president remains in excellent health, which I think all of you witness on a daily basis here,” she said.

White House physician Sean Barbabella wrote in an April memo that Trump “remains in excellent physical health” and is “fully fit” to perform the duties of the presidency.

Read Thursday’s full memo from Barbabella below.

President Donald Trump’s health status update.

Courtesy: The White House

This is developing news. Please check back for updates.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More